ICMRA report on best practices against antimicrobial resistance
by Giuliana Miglierini Antimicrobial resistance (AMR) is the consequence of mutations that allow microbes to survive pharmacological treatment.…
The new European Innovation Agenda
by Giuliana Miglierini A new piece of legislation adds to the framework supporting the new paradigms set forth…
Webinar: Antimicrobial Resistance – How do we make Antibiotics Economically Viable again?
Our first EIPG Webinar of 2022 will be held in conjunction with PIER and University College Cork on…
First steps of the HERA Authority and comments from industrial and medical associations
by Giuliana Miglierini The new European Health Emergency preparedness and Response Authority (HERA) has started its operative phase.…
Consultation on the reform of the European pharmaceutical legislation
by Giuliana Miglierini A new step in the review of the overall framework governing the pharmaceutical sector has…